Impact of respiratory syncytial virus on Streptococcus pneumoniae resistance to β-lactam antibiotics: an investigative study in children
- PMID: 40490732
- PMCID: PMC12147270
- DOI: 10.1186/s12866-025-04066-5
Impact of respiratory syncytial virus on Streptococcus pneumoniae resistance to β-lactam antibiotics: an investigative study in children
Abstract
Background: This study characterizes the molecular interplay between respiratory syncytial virus (RSV) glycoproteins (G/F) and Streptococcus pneumoniae (S.pn) penicillin-binding proteins (PBPs), while evaluating RSV's potential role in modulating S.pn β-lactam resistance.
Methods: Protein docking and pull-down assays assessed G/F-PBP interactions. In vitro RSV-S.pn co-culture experiments evaluated β-lactam susceptibility (MIC determination). We retrospectively analyzed 2012-2021 antimicrobial resistance data from 1-59-month-old community-acquired pneumonia patients at Chongqing Medical University Children's Hospital with confirmed S.pn and/or RSV nasopharyngeal carriage.
Results: Computational modeling revealed low G/F-PBP binding affinity (iPTM < 0.6), corroborated by absent PBP1a interaction in pull-down assays. RSV exposure did not alter S.pn β-lactam MICs (penicillin/amoxicillin ≤ 2 µg/mL; cefepime/cefotaxime ≤ 1 µg/mL; meropenem ≤ 0.25 µg/mL). Retrospective data showed elevated penicillin resistance in RSV + S.pn co-detections vs. S.pn alone during 2012 (2.8% vs. 40.9%), 2017 (2.8% vs. 30.4%), and 2018 (6.2% vs. 38.6%) (all p < 0.001). No RSV-associated resistance increases occurred for amoxicillin, cephalosporins, or meropenem.
Conclusions: RSV demonstrates negligible impact on S.pn β-lactam resistance mechanisms, elevated resistance rates to amoxicillin and cephalosporins necessitate enhanced antimicrobial stewardship through diagnostic-guided prescribing and resistance surveillance to optimize β-lactam efficacy in pediatric care.
Keywords: Streptococcus pneumoniae; Antibiotic resistance; Glycoprotein; Penicillin-binding protein; Respiratory syncytial virus.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: All procedures of this study involving humans (individuals, medical records, human samples, and clinical isolates) were reviewed and approved by the Ethics Committee of Children’s Hospital affiliated to Chongqing Medical University(File No. 2023 − 492). All methods were performed in accordance with the relevant guidelines and regulations. Due to the retrospective nature of the study, the Ethics Committee of Children’s Hospital affiliated to Chongqing Medical University waived the need of obtaining informed consent. Clinical trial number: not applicable. This study adhered to the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures




References
-
- Liu YN, Zhang YF, Xu Q, Qiu Y, Lu QB, Wang T, et al. Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a National surveillance study. Lancet Microbe. 2023;4(5):e330–9. - PubMed
-
- (WHO) WHO. WHO updates list of drug-resistant bacteria most threatening to human health. 2024.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous